CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,470,000 | -54.4% | 155,587 | -38.1% | 5.23% | -60.1% |
| Q2 2017 | $7,607,000 | +1449.3% | 251,300 | +645.2% | 13.10% | +1927.9% |
| Q1 2017 | $491,000 | -82.6% | 33,721 | -83.0% | 0.65% | -71.1% |
| Q3 2016 | $2,817,000 | +2745.5% | 198,291 | +400.9% | 2.23% | +2527.1% |
| Q2 2016 | $99,000 | -63.1% | 39,590 | -6.6% | 0.08% | -69.8% |
| Q1 2016 | $268,000 | -37.1% | 42,410 | -38.9% | 0.28% | -10.5% |
| Q4 2015 | $426,000 | – | 69,360 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |